Results 11 to 20 of about 2,699 (167)

"Reckoning with Colin Rowe: ten architects take position"

Zarch, 2016
Reckoning With Colin Rowe es un pequeño, pero muy inteligente y desinhibido, libro sobre Colin Rowe, publicado después de su fallecimiento y editado por el arquitecto, escritor y profesor Emmanuel Petit.
José Ángel Sanz Esquide
doaj   +5 more sources

(Dossier Colin Rowe) Cervantes, Rowe, Venturi&Scott Brown; manieras...

Astragalo
El artículo aborda la figura intelectual del angloestadounidense Colin Rowe, de una forma fragmentada, incidiendo en algunos aspectos que han marcado hitos en la historiografía y la interpretación arquitectónica del siglo XX.
José López-Canti
doaj   +3 more sources

Colin Rowe: Space as well-composed illusion [PDF]

Journal of Art Historiography, 2011
Architectural historian Colin Rowe, although well known for his intriguing analytical writings on modern architecture, rarely examined architectural space as a scholarly subject-matter.
Christoph Schnoor
doaj   +2 more sources

Ambichronous historiography: Colin Rowe and the teaching of architectural history [PDF]

Journal of Art Historiography, 2016
Ianus Architectus is the Latin combination of the Architect with the ancient Roman god of beginnings and ends, pasts and futures, Janus. It represents the dual act of both seeing past-and-future (Janus’ two faces), and producing (architecture ...
Braden Engel
doaj   +2 more sources

Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectories. [PDF]

Alzheimers Dement
Abstract INTRODUCTION With increased uptake in disease‐modifying treatments for amyloid beta (Aβ) removal, it is important to measure performance of highly sensitive plasma biomarkers to detect the presence of Aβ and tau in cognitively impaired populations.
Cánovas R, Fowler CJ, Feizpour A, Dóre V, Bourgeat P, Saad ZS, Triana-Baltzer G, Kolb HC, Vandijck M, Kollmorgen G, Quijano-Rubio C, Fripp J, Laws S, Bannon AW, Blennow K, Zetterberg H, Rainey-Smith S, Mathotaarachchi S, Rowe CC, Masters CL, Doecke JD, AIBL Research Group.   +21 more
europepmc   +2 more sources

Correlations of amyloid accumulation, brain atrophy and cognitive decline in emergent Alzheimer's disease [PDF]

Alzheimers Dement
Abstract Background Amyloid‐β (Aβ) deposition and dysfunction of the cholinergic basal forebrain (BF) system are early pathological features in Alzheimer's disease (AD). Given the continuous nature of Aβ accumulation, the extent of the corresponding changes in brain structure and cognitive performance at the emergent stage of AD, characterized by ...
Xia Y, Dore V, Fripp J, Bourgeat P, Lim Y, Laws S, Fowler C, Rowe C, Masters C, Coulson E, Maruff P.   +10 more
europepmc   +2 more sources

Mesial temporal tau pathology impacts basal forebrain degeneration in early Alzheimer's disease. [PDF]

Alzheimers Dement
Abstract INTRODUCTION The cholinergic basal forebrain system, particularly the nucleus basalis of Meynert (Ch4), is selectively vulnerable to amyloid beta (Aβ) and tau in Alzheimer's disease (AD). Their interplay may be a critical driver of AD progression, but remains poorly understood. METHODS Data from 779 older individuals in the Australian Imaging,
Xia Y, Dean MW, Bourgeat P, Krishnadas N, Maruff P, Masters CL, Villemagne VL, Fripp J, Rowe CC, Doré V, Coulson EJ.   +10 more
europepmc   +2 more sources

Harmonizing neuropsychological test data across prospective studies. [PDF]

Alzheimers Dement
Abstract INTRODUCTION Alzheimer's disease (AD) research relies on large datasets and advanced statistical models. However, individual population studies often lack sufficient sample size for conclusive results. Harmonizing cognitive test data across studies can address this gap, despite differences in testing protocols.
Shishegar R, Doecke JD, Lim YY, Bourgeat P, Dore V, Tallapragada B, Laws SM, Porter T, Burnham S, Feizpour A, Gillman A, Weiner M, Hassenstab J, Rowe CC, Villemagne VL, Masters CL, Fripp J, Sohrabi H, Maruff P, Alzheimer's Disease Neuroimaging Initiative, OASIS‐3, and the Australian Imaging Biomarkers and Lifestyle flagship study of ageing.   +21 more
europepmc   +2 more sources

Combining Lumipulse pTau217 and Aβ42 as confirmatory tests for Aβ pathology prior to DMT [PDF]

Alzheimers Dement
Abstract Background With the increasing number of countries approving disease‐modifying therapies (DMTs) for patients with either Mild Cognitive Impairment (MCI) or mild Alzheimer's disease (AD), it is vitally important to streamline treatment assessment processes. Blood‐based biomarkers (BBMs) have been suggested as rivals to cerebrospinal fluid (CSF)
Doecke J, Chenna A, Lo M, Badal Y, Yee B, Martone R, Petropoulos C, Fowler C, Laws S, Rainey‐Smith S, Martins R, Rowe C, Masters C, Winslow J.   +13 more
europepmc   +2 more sources

Heterogeneous tau patterns in atypical AD are explained by connectivity‐associated tau progression [PDF]

Alzheimers Dement
Abstract Background The link between regional tau load and clinical manifestation of Alzheimer's disease (AD) highlights the importance of characterizing spatial tau distribution. In typical (memory‐predominant) AD, the spatial progression of tau pathology mirrors the functional connections from temporal lobe epicenters. However, atypical (non‐amnestic‐
de Bruin H, Groot C, Alzheimer's Disease Neuroimaging Initiative (ADNI), Barthel H, Bischof G, Blazhenets G, Boellaard R, Boon B, Brendel M, Cash D, Coath W, Day G, Dickerson B, Doering E, Drzezga A, van Dyck C, van Eimeren T, van der Flier W, Fredericks C, Fryer T, van de Giessen E, Gordon B, Radford J, Grinberg L, Hansson O, Hobbs D, Höglinger G, Hönig M, Irwin D, Jones P, Josephs K, Katsumi Y, Joie R, Lee E, Levin J, Malpetti M, McGinnis S, Mecca A, Mohanty R, Nasrallah I, O'Brien J, O'Dell R, Palleis C, Perneczky R, Phillips J, Putcha D, Rabinovici G, Rahmouni N, Rosa‐Neto P, Rowe J, Rullmann M, Sabri O, Saur D, Schildan A, Schott J, Schroeter M, Seeley W, Servaes S, Sintini I, Smith R, Spina S, Stevenson J, Stomrud E, Strandberg O, Therriault J, Tideman P, Touroutoglou A, Trainer A, Visser D, Wekselman F, Weston P, Whitwell J, Wolk D, Yong K, Pijnenburg Y, Franzmeier N, Ossenkoppele R.   +76 more
europepmc   +2 more sources